Novartis AGFRA:NOT0 +2.79%82 Days Inventory is 164.55 as of Mar. 2026, which is 4% below its 10-year median of 171.13. GuruFocus rates FRA:NOT0 with a GF Score™ of 82/100 and a GF Value™ of €14.46 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 918 Drug Manufacturers companies, Novartis AG ranks worse than 51.09% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Novartis AG's Average Total Inventories for the
three
months ended in Mar. 2026 was €5,396 Mil. Novartis AG's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €2,992 Mil.
Hence, Novartis AG's Days Inventory for the
three
months ended in Mar. 2026 was 164.55.
The historical rank and industry rank for Novartis AG's Days Inventory or its related term are showing as below:
FRA:NOT0'
s Days Inventory Range Over the Past 10 Years
Min: 128.46 Med: 171.13 Max: 216.9
Current: 166.33
During the past 13 years, Novartis AG's highest Days Inventory was 216.90. The lowest was 128.46. And the median was 171.13.
FRA:NOT0's Days Inventory is ranked worse than 51.09% of 918
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs FRA:NOT0: 166.33
Novartis AG's Days Inventory
declined
from Mar. 2025 (165.95) to Mar. 2026 (164.55).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Novartis AG's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.55.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Novartis AG's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.46.
Novartis AG (FRA:NOT0) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Novartis AG's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Novartis AG's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Novartis AG Days Inventory Related Terms
Novartis AG Days Inventory Historical Data
* Premium members only.
The historical data trend for Novartis AG's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:NOT0 vs LLY, JNJ, ABBV: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, Novartis AG's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novartis AG Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Days Inventory distribution charts can be found below:
* The bar in red indicates where Novartis AG's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novartis AG (FRA:NOT0) has a Days Inventory of 164.55 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Novartis AG and its competitors. This is near median its historical median of 171.13. Over the past decade, Novartis AG's Days Inventory has ranged from 128.46 to 216.90. According to the industry distribution chart, Novartis AG ranks #469 out of 918 companies in the Drug Manufacturers industry, placing it in the top 51.1%.
Is Novartis AG's Days Inventory too high?
Novartis AG's current Days Inventory of 164.55 is near median its 10-year median of 171.13. Over the past 10 years, this metric has ranged from a low of 128.46 to a high of 216.90. The Drug Manufacturers industry median Days Inventory is 164.43. Novartis AG's value of 164.55 is 0.1% above this industry median. Based on the distribution chart, Novartis AG ranks #469 out of 918 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Novartis AG has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Novartis AG's Days Inventory compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Novartis AG ranks #469 out of 918 companies for Days Inventory. This places Novartis AG in the lower half of its industry. The industry median Days Inventory is 164.43. Novartis AG's value of 164.55 is 0.1% above this benchmark. Historically, Novartis AG's own Days Inventory has ranged from 128.46 to 216.90 over the past decade. While the company's 10-year median is 171.13 vs. the industry median of 164.43, Novartis AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Novartis AG's current Days Inventory of 164.55 is 0.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Novartis AG and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novartis AG's current Days Inventory is 164.55, which is near median its own 10-year median of 171.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novartis AG stock overvalued right now?
Based on GuruFocus' analysis, Novartis AG (FRA:NOT0) is currently considered Modestly Overvalued. The stock's GF Value™ is €14.46, compared to a current price of €18.40 — trading 27.2% above its estimated fair value. The current Days Inventory is 164.55, which is near median its 10-year median of 171.13 and 0.1% above the Drug Manufacturers industry median of 164.43. Novartis AG's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Novartis AG (FRA:NOT0), the current Days Inventory is 164.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Novartis AG (FRA:NOT0) Overvalued in 2026?
Based on GuruFocus' analysis, Novartis AG stock appears to be overvalued.
The current stock price of €18.40 is trading 27.2% above its estimated GF Value™ of €14.46.
GuruFocus considers Novartis AG to be Modestly Overvalued.
Key valuation signals for FRA:NOT0:
Days Inventory: 164.55 (near median its 10-year median of 171.13)
GF Value™: €14.46 vs. price of €18.40 (27.2% above fair value)
Industry Position: 0.1% above the Drug Manufacturers median (#469 of 918)
No single metric tells the full story. See the FRA:NOT0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
82GF Score
Get the complete analysis for FRA:NOT0
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:NOT0 has been successfully added to your 
